| Title: |
Members of the microRNA-106a-363 Cluster Associate with Unfavorable Outcome in Adult Acute Myeloid Leukemia Patients and Promote Leukemogenesis invivo through Increased Metabolic Activity |
| Authors: |
Sperb, Nadine, Krowiorz, Kathrin, Grasedieck, Sarah, Rueß, Christoph, Pochert, Nicole, Schneider, Edith, Johansson, Pegah, Malmberg, Erik Delsing, Arabanian, Laleh, Maetzig, Tobias, Fogelstrand, Linda, Döhner, Hartmut, Palmqvist, Lars, Rösler, Reinhild, Wiese, Sebastian, Calzia, Enrico, Rouhi, Arefeh, Kuchenbauer, Florian |
| Source: |
Blood; November 2018, Vol. 132 Issue: Supplement 1 p3924-3924, 1p |
| Abstract: |
Döhner: Astellas: Consultancy, Honoraria; AbbVie: Consultancy, Honoraria; Bristol Myers Squibb: Research Funding; Astex Pharmaceuticals: Consultancy, Honoraria; Janssen: Consultancy, Honoraria; Bristol Myers Squibb: Research Funding; Celator: Consultancy, Honoraria; Jazz: Consultancy, Honoraria; Astex Pharmaceuticals: Consultancy, Honoraria; Jazz: Consultancy, Honoraria; Celator: Consultancy, Honoraria; Pfizer: Research Funding; Sunesis: Consultancy, Honoraria, Research Funding; AROG Pharmaceuticals: Research Funding; Agios: Consultancy, Honoraria; Celgene: Consultancy, Honoraria, Research Funding; Amgen: Consultancy, Honoraria; Astellas: Consultancy, Honoraria; Amgen: Consultancy, Honoraria; AROG Pharmaceuticals: Research Funding; Seattle Genetics: Consultancy, Honoraria; Sunesis: Consultancy, Honoraria, Research Funding; Pfizer: Research Funding; Seattle Genetics: Consultancy, Honoraria; Novartis: Consultancy, Honoraria, Research Funding; Celgene: Consultancy, Honoraria, Research Funding; Agios: Consultancy, Honoraria; Novartis: Consultancy, Honoraria, Research Funding; AbbVie: Consultancy, Honoraria; Janssen: Consultancy, Honoraria. |
| Database: |
Supplemental Index |
